Curated by Dr. Rohan Navelkar – Recent Advances in ENT
Studies reviewed from Oct–Dec 2024
Source: ENTtoday
Summary from uploaded document: IV tranexamic acid (TXA) protocols significantly decreased takebacks to OT for pediatric post-tonsillectomy hemorrhage.
Across multiple studies this quarter, TXA—whether systemic or topical—showed:
Reduced intraoperative blood loss
Shorter operative time
Better visualization
Lower re-bleed rates
Clinical Takeaway:
A unified TXA protocol should be part of every high-volume tonsil surgery center.
Source: PubMed (Zheng et al.)
Large UK Biobank data showed no increase in COVID susceptibility among adults who had undergone tonsillectomy in childhood.
Takeaway:
Tonsil removal does not impair long-term antiviral immunity.
3. CPAP & Obstructive Sleep Apnea: New Insights Beyond Breathing
Multiple studies highlighted new systemic effects of OSA and CPAP:
a. CPAP reduces risk of retinal disease
OSA patients have higher risk of retinal microvascular complications. CPAP reduced this risk.
b. CPAP improves marital satisfaction & sexual health
OSA affects intimacy; CPAP therapy significantly improved relationship dynamics.
c. AD109 (trial drug) shows promise for OSA
A new combination drug (adenosine A1 agonist + noradrenergic agent) demonstrated effective upper-airway tone improvement.
Two studies this quarter reinforced the ENT–neurology connection:
Poor sleep correlates with increased dementia risk (Medgami).
Sleep disturbances strongly correlate with tinnitus severity (PubMed).
Clinical takeaway:
Aggressively treating nasal obstruction and OSA is a cognitive-protection strategy, not just respiratory care.
Keywords
Tonsillectomy bleeding TXA protocol, OSA research 2024, CPAP relationship outcomes, sleep tinnitus link, airway surgery advances